Company · CIK 0001518520
Icagen, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 10-QQuarterly update0001213900-20-004183 · 13.3 MBSEC(opens sec.gov)
- 8-KCurrent report0001213900-19-017040 · 377.8 KBSEC(opens sec.gov)
- 10-QQuarterly update0001213900-19-016342 · 5.4 MBSEC(opens sec.gov)
- 10-QQuarterly update0001213900-19-008759 · 5.2 MBSEC(opens sec.gov)
- 8-KCurrent report0001213900-19-007698 · 753.4 KBSEC(opens sec.gov)
- 10-KAnnual report0001213900-19-006256 · 8.8 MBSEC(opens sec.gov)
- SC 13D/AIcagen, Inc.0001213900-19-000556 · 59.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001213900-18-016316 · 42.2 KBSEC(opens sec.gov)
- 10-QQuarterly update0001213900-18-016174 · 6.4 MBSEC(opens sec.gov)
- 8-K/AIcagen, Inc.0001213900-18-013278 · 6.9 MBSEC(opens sec.gov)
Insiders
- Cunningham, Richard AnthonyChief Executive Officer
- KABATZNIK CLIVEDirector
- KORB MARK JOHNChief Financial Officer
- Krafte DouglasChief Scientific Officer
- Palmieri VincentDirector
- Roffman EdwardDirector
- TAGLICH MICHAEL NDirector, 10% Owner
- TAGLICH ROBERT10% Owner
- TYSON TIMOTHYDirector, 10% Owner
- Warner BenjaminDirector, Chief Scientific Officer, 10% Owner
Tickers
No tickers on record.
Addresses
business
4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK
DURHAM, NC, 27703
mailing
4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK
DURHAM, NC, 27703
Former names
- XRpro Sciences, Inc.2015-08-14
- Caldera Pharmaceuticals Inc2014-11-25
Same industry
Related Services-Commercial Physical & Biological Research companies
View all Services-Commercial Physical & Biological Research companies